OKYO Pharma
OKYO · NASDAQ
$1.37−$0.03 (−2.14%)TodayMarket closed ·
Prev close $1.40
Who owns OKYO
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 50.8% of OKYO’s shares.
- Cerrone (Gabriele M)20.1%
- Sirenia Capital Management LP7.7%
- Chernett (Jorey)7.2%
- Woodline Partners LP7.0%
- Next 6 largest institutions8.8%
- All other shareholders49.2%
| Holder | Shares | % of shares |
|---|---|---|
| Cerrone (Gabriele M) | 10.53M | 20.06% |
| Sirenia Capital Management LP | 4.05M | 7.72% |
| Chernett (Jorey) | 3.80M | 7.25% |
| Woodline Partners LP | 3.65M | 6.96% |
| Fonda (Laura) | 1.93M | 3.67% |
| Stonepine Capital Management, LLC | 863.00K | 1.64% |
| Maven Investment Partners US Ltd. | 809.32K | 1.54% |
| Balyasny Asset Management LP | 580.60K | 1.11% |
| Opaleye Management Inc. | 375.20K | 0.71% |
| UBS Financial Services, Inc. | 55.01K | 0.10% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 12.09K | 0.02% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $136.01K (7 trades) of OKYO on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Patil Rajkumar V. | Award | 3.36K | $5.01K |
| Patil Rajkumar V. | Buy | 3.36K | $5.01K |
| Dempsey Robert John | Buy | 15.00K | $23.09K |
| Dempsey Robert John | Award | 15.00K | $23.09K |
| Mantelli Flavio | Buy | 20.00K | $28.00K |
| BRANCACCIO JOHN P | Buy | 5.00K | $7.38K |
| JACOB GARY S | Buy | 3.50K | $4.90K |
| CERRONE GABRIELE M | Buy | 22.50K | $32.63K |
| BRANCACCIO JOHN P | Award | 5.00K | $7.38K |
| JACOB GARY S | Award | 3.50K | $4.90K |
Short interest
Settled Sep 30, 2026
- Shares short
- 34.64K
- Days to cover
- 1.00
- % of shares outstanding
- 0.07%
- Average daily volume
- 76.32K
- Change since last report
- −17.8%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.